Theravance Biopharma, Inc. (TBPH)

20.33 +0.68 (+3.46%) USD  |  NASDAQ  |  Jan 13, 16:00
20.34 +0.02 (+0.07%) Pre-Market: 20:00
More

Theravance Biopharma Other Long Term Liabilities (Quarterly)

Other Long Term Liabilities (Quarterly) Chart

View Other Long Term Liabilities (Quarterly) for TBPH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Other Long Term Liabilities (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Other Long Term Liabilities (Quarterly) Range, Past 5 Years

View Other Long Term Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Other Long Term Liabilities (Quarterly) Benchmarks

View Other Long Term Liabilities (Quarterly) Benchmarks
Start Trial
Corcept Therapeutics, Inc. --
Perspective Therapeutics, Inc. Upgrade
Skye Bioscience, Inc. --
Kyntra Bio, Inc. Upgrade
Myomo, Inc. --